Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Capital Expenditures (2018 - 2026)

Viemed Healthcare filings provide 8 years of Capital Expenditures readings, the most recent being -$4.8 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 140.36% to -$4.8 million in Q4 2025 year-over-year; TTM through Sep 2025 was $16.6 million, a 68.09% decrease, with the full-year FY2024 number at $37.8 million, up 44.76% from a year prior.
  • Capital Expenditures hit -$4.8 million in Q4 2025 for Viemed Healthcare, down from $819000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $26.1 million in Q4 2023 to a low of -$10.8 million in Q3 2022.
  • Median Capital Expenditures over the past 5 years was $4.0 million (2022), compared with a mean of $4.4 million.
  • The widest YoY moves for Capital Expenditures: up 5515.62% in 2021, down 179600.0% in 2021.
  • Viemed Healthcare's Capital Expenditures stood at $6.7 million in 2021, then tumbled by 262.81% to -$10.8 million in 2022, then skyrocketed by 340.47% to $26.1 million in 2023, then tumbled by 54.65% to $11.8 million in 2024, then tumbled by 140.36% to -$4.8 million in 2025.
  • The last three reported values for Capital Expenditures were -$4.8 million (Q4 2025), $819000.0 (Q3 2025), and $330000.0 (Q2 2025) per Business Quant data.